
Glimedom M1 Tablets by Kivonyx Healthcare Pvt. Ltd. contain Glimepiride and Metformin Hydrochloride Prolonged Release, a prescription anti-diabetic combination used for managing Type 2 Diabetes Mellitus in selected adults. Glimepiride is a sulfonylurea medicine that stimulates insulin release from pancreatic beta cells, while Metformin helps reduce hepatic glucose production and improve insulin sensitivity. Glimedom M1 may be prescribed when combination therapy is clinically appropriate for managing fasting and post-meal blood glucose levels. Its prolonged-release formulation is designed to release Metformin gradually according to verified product specifications. Available in a pack of 10 × 15 tablets, Glimedom M1 should be taken according to a registered medical practitioner's prescription, considering kidney function, hypoglycaemia risk, ingredient strengths, and individual treatment requirements.
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Kivonyx Healthcare Pvt. Ltd. is a leading pharmaceutical company in Ahmedabad, with a primary focus on providing high-quality healthcare products to its clients and customers that cater to a diverse range of health disorders. We are deeply committed to offering innovative healthcare solutions that improve patients’ health and enhance their quality of life. In everything we do or engage with, the foundation remains the same; i.e. an unwavering dedication to quality and innovation.
All our products are manufactured in WHO GMP-certified facilities. With the backing of a strong network, our product range reaches the entire nation with a well-structured distribution channel. Thus, we are highly reliable as a brand when it comes to taking care of the ever-evolving needs of the healthcare community. We offer a wide range of pharmaceutical products for improving patient care, ranging from antibiotics and antifungal treatments to advanced vitamin supplements.
We believe in continuous improvement through research and development, enabling us to stay at the forefront of medical advancements. By combining state-of-the-art technology with a patient-centric approach, we ensure that our solutions not only meet but exceed the expectations of the healthcare sector.